This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. KANSAS CITY, Kan. — Doctors often treat ...
On Tuesday, FDA announced that it has approved the first bioresorbable polymer stent, a development bound to spur competition between Abbott that makes the device and Boston Scientific that makes a ...
WASHINGTON (AP) – A medical implant that slowly dissolves into the body could be the answer to long-standing safety concerns with devices used to treat clogged arteries. But not so fast, say experts.
Natick, MA – Boston Scientific Corporation’s WallFlex® Biliary RX Fully Covered Stent has received Health Canada approval for the treatment of benign biliary strictures, which supplements its current ...
Biliary stent migration represents a significant clinical challenge, occurring when stents inserted to relieve biliary obstructions dislodge from their intended positions. This phenomenon can lead to ...
Boston Scientific published a multinational study in the journal Gastroenterology that evaluates the removability and long-term stricture resolution of benign biliary strictures in relation to the use ...
New York, Nov. 27, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Asia-Pacific Pancreatic and Biliary Stent Procedures Outlook to 2025 - Endoscopic Retrograde ...
More Than 100,000 People with Coronary Artery Disease Have Been Treated with Absorb Abbott on Track to Submit for Regulatory Approvals of Absorb in the U.S., Japan and China PARIS, Abbott announced ...
Time-period from presentation to anticipated surgery: if a patient may undergo pancreaticoduodenectomy within a few days of presentation and is a candidate for surgery, no instrumentation may be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback